Pharmaceuticals - Community Register


Community list of not active orphan medicinal products


Product information


EU orphan designation number: EU/3/10/728
Active ingredient: Davunetide
Indication: Treatment of progressive supranuclear palsy
Sponsor: FGK Representative Service GmbH
Heimeranstraße 35, D-80339 München, Deutschland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
25/03/2010 Orphan designation EMEA/OD/129/09 (2010)2053 of 23/03/2010
19/04/2013 Removal of orphan designation from Community Register